DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today confirmed that it would report its financial results for the third quarter of 2010 on Wednesday, November 10, 2010 before the opening of the financial markets. The announcement will be followed by a business update conference call with the investment community scheduled for later that afternoon on Wednesday, November 10, 2010 at 4:30 PM ET. On the call Neoprobe’s President and CEO, David Bupp, Senior Vice President, Pharmaceutical Research and Clinical Development, Dr. Frederick Cope, and Senior Vice President and CFO, Brent Larson, will provide a business update, review results for the third quarter of 2010 and discuss recent corporate events. The conference call can be accessed as follows:
